Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Prasad S. Kulkarni, Ashish Sahai, Bhagwat Gunale, Rajeev M Dhere
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Taylor & Francis Group 2017-04-01
Σειρά:	Expert Review of Vaccines
Θέματα:	rabivax-s rabies purified vero cell rabies vaccine safety immunogenicity
Διαθέσιμο Online:	http://dx.doi.org/10.1080/14760584.2017.1294068

Παρόμοια τεκμήρια

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
ανά: Piyada Angsuwatcharakon, κ.ά.
Έκδοση: (2018-02-01)

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
ανά: Jia Li, κ.ά.
Έκδοση: (2024-12-01)

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
ανά: D.J. Briggs, κ.ά.

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
ανά: Jing Wang, κ.ά.
Έκδοση: (2017-01-01)

DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
ανά: A. L. Kravtsov, κ.ά.
Έκδοση: (2019-08-01)

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens
ανά: Hua-Kun Lv, κ.ά.
Έκδοση: (2025-02-01)

Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis
ανά: Scott Preiss, κ.ά.
Έκδοση: (2018-06-01)

Study on immune persistence of the CTN-1V strain rabies vaccine in humans
ανά: Lidong Wang, κ.ά.
Έκδοση: (2024-03-01)

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
ανά: Nianmin Shi, κ.ά.
Έκδοση: (2017-06-01)

Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination
ανά: Zheng-Gang Zhu, κ.ά.
Έκδοση: (2018-11-01)

Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine
ανά: Jia Li, κ.ά.
Έκδοση: (2024-12-01)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
ανά: Pornthep Chanthavanich, κ.ά.
Έκδοση: (2018-04-01)

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures
ανά: Xiaohong Wu, κ.ά.
Έκδοση: (2023-08-01)

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposureResearch in context
ανά: Gagandeep Kang, κ.ά.
Έκδοση: (2023-07-01)

Infection and Prevention of Rabies Viruses
ανά: Shiu-Jau Chen, κ.ά.
Έκδοση: (2025-02-01)

Development of mRNA rabies vaccines
ανά: Zixin Fang, κ.ά.
Έκδοση: (2024-12-01)

Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
ανά: Thomas Moulenat, κ.ά.
Έκδοση: (2020-03-01)

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China
ανά: Zhenzhen Liang, κ.ά.
Έκδοση: (2024-11-01)

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial
ανά: Lei Zhang, κ.ά.
Έκδοση: (2021-08-01)

A STUDY OF THE ULTRASTRUCTURE OF THE SURFACE OF THE TRANSPLANTABLE LINE VERO CELLS INFECTED WITH THE RABIES VIRUS (RABV, LISSAVIRUS, RHABDOVIRIDAE)
ανά: S. V. Generalov, κ.ά.
Έκδοση: (2017-10-01)

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial
ανά: Xingyu Zhou, κ.ά.
Έκδοση: (2019-04-01)

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
ανά: Heng Shen, κ.ά.
Έκδοση: (2021-02-01)

Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran
ανά: Pooneh Rahimi, κ.ά.
Έκδοση: (2014-08-01)

Rabies and rabies immunobiological preparations: vaccinations Pasteur to the contemporary biotechnology
ανά: E. G. Abramova, κ.ά.
Έκδοση: (2019-11-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
ανά: Xiaoyuan Huang, κ.ά.
Έκδοση: (2023-01-01)

Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified
ανά: Hanna K, κ.ά.
Έκδοση: (2018-06-01)

Retrospective study of rabies epidemiology in Ukraine (1950-2019)
ανά: I. F. Makovska, κ.ά.
Έκδοση: (2020-03-01)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
ανά: Irina Matveeva, κ.ά.
Έκδοση: (2022-09-01)

Management of rabies
ανά: J. Weyer, κ.ά.
Έκδοση: (2019-07-01)

The Formation of the Eastern Africa Rabies Network: A Sub-Regional Approach to Rabies Elimination
ανά: Emily G Pieracci, κ.ά.
Έκδοση: (2017-07-01)

Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings
ανά: Sunil Karande, κ.ά.
Έκδοση: (2015-07-01)

A case of human rabies in the Urban Area of Ribeirão Preto, SP, Brazil
ανά: SILVA Jorgete M., κ.ά.
Έκδοση: (1997-01-01)

A case of human survival of rabies, South Africa
ανά: Jacqueline Weyer, κ.ά.
Έκδοση: (2016-07-01)

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
ανά: Weerawan Hattasingh, κ.ά.
Έκδοση: (2022-01-01)

Amino Acid Mutation in Position 349 of Glycoprotein Affect the Pathogenicity of Rabies Virus
ανά: Jun Luo, κ.ά.
Έκδοση: (2020-04-01)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study
ανά: Gadey Sampath, κ.ά.
Έκδοση: (2017-07-01)

Factors related to vaccines for both patients exposed with rabies and dogs
ανά: Lam Quy Ngo, κ.ά.
Έκδοση: (2022-03-01)

Factors related to vaccines for both patients exposed with rabies and dogs
ανά: Lam Quy Ngo, κ.ά.
Έκδοση: (2022-03-01)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
ανά: Anurag Agarwal, κ.ά.
Έκδοση: (2022-11-01)

MANAJEMEN INFEKSI RABIES BERISIKO TINGGI: STUDI KASUS TANPA SERUM ANTI-RABIES
ανά: Mahdika Ambarwaty, κ.ά.
Έκδοση: (2023-12-01)